Merit Medical Systems has announced the commercial launch of the PreludeSYNC EVO radial compression device in European, Middle Eastern and African markets.
The product has clearance from the US Food and Drug Administration (FDA) and has CE mark in the EU for use in diagnostic cardiac catheterisation procedures and percutaneous coronary interventions (PCIs).
Merit’s PreludeSYNC EVO is a sterile, single-use, disposable device used to assist in gaining haemostasis of the arterial percutaneous access site following catheterisation procedures.
“PreludeSYNC EVO adds to our extensive line of radial compression devices that support PCI from start to finish. It was developed to meet the evolving clinical and health economic needs of physicians, administrators and catheter lab teams around the globe. Our intent with PreludeSYNC EVO, the latest innovation in our premium cardiology product portfolio, is to provide physicians with even more procedural clarity and uniformity and their patients with safety and comfort,” says Fred P Lampropoulos, Merit Medical’s founder, chair, and Chief Executive Officer.
The device has a large, clear window area, which provides unobstructed site visibility. It is also optimised for diffuse and uniform balloon pressure. The safety features include a specialised connection and Slip-n-Lock cap that secures the syringe during inflation and deflation. A soft, comfortable band, which is easy to secure, adjust and clean, is available in 24 and 29cm sizes.
The PreludeSYNC EVO is immediately available in the EU, with registration coming in Middle East and Africa.
